Hematologic Malignancies: Clinical Trials

19 trials for Hematologic Malignancies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 3 terminated, 3 unknown, 2 recruiting. 19 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable19Completed 10, Terminated 3, Unknown 3, Recruiting 2, Not yet recruiting 1

Follow Hematologic Malignancies: new trials by email Literature Review of Hematologic Malignancies trials Research Report on Hematologic Malignancies

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Resistance Training on Recovery During Hematopoietic Stem Cell Transplantation
8-week Elastic Band Resistance Training Program - Hematologic Malignancies, Hematopoietic Stem Cell Transplantation
Not applicableNot yet recruitingTaipei Veterans General Hospital, Taiwan862026-10-122026-10-14
Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
Allogeneic donor TCRαβ+/CD19+ cell-depleted peripheral blood mononuclear cells - Hematologic Malignancies
Not applicableRecruitingUniversity of Wisconsin, Madison382026-02-262026-09-14
Murottal as Adjunctive Intervention in Pediatric
Murottal Intervention - Pediatric Cancer, Hematologic Malignancies
Not applicableCompletedUniversitas Airlangga202025-12-192026-10-09
Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L.
Blood sample - Hematologic Malignancies, Thrombopenia
Not applicableCompletedCentre Hospitalier Annecy Genevois482024-06-262025-02-13
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Preference Reporting to Improve Management and Experience (PRIME) - Hematologic Malignancies, Lymphoma
Not applicableRecruitingUNC Lineberger Comprehensive Cancer Center5002024-06-212026-08-14
An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
Inpatient serious illness care program - Hematologic Malignancies
Not applicableCompletedUniversity of Rochester412022-11-232026-03-31
The Effect of Lavender Oil on Fatigue and Sleep Quality
Lavander oil Aromatherapy, Saline Solution - Hematologic Malignancies, Patient Participation
Not applicableUnknownIstanbul Aydın University1002022-01-012023-04-11
Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology
Additional blood sample - Vancomycin, Hematologic Malignancies
Not applicableUnknownCiusss de L'Est de l'Île de Montréal402021-02-012021-02-17
Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia
Mirasol platelets (MIR PLTs), Reference platelets (REF PLTs) - Hematologic Malignancies, Hypoproliferative Thrombocytopenia
Not applicableTerminatedTerumo BCTbio4222017-05-052021-08-19
Matching Patients With Hematologic Malignancy to Adequate Clinical Trials
Matching on the basis of molecular analysis, Matching on the basis of physician's choice - Hematologic Malignancies
Not applicableUnknownSeoul National University Hospital902016-01-012017-10-26
A Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital Care
Home Care - Hematologic Malignancies
Not applicableCompletedDuke University562012-02-012019-07-16
Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets
Non-neutropenic Diet - Hematologic Malignancies
Not applicableCompletedDuke University472009-04-012013-05-10
Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation
TOTAL LYMPHOID IRRADIATION - HEMATOLOGIC MALIGNANCIES
Not applicableCompletedFondazione EMN Italy Onlus202007-11-012024-03-13
Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies
Pegfilgrastim - Hematologic Malignancies
Not applicableTerminatedDartmouth-Hitchcock Medical Center72007-01-012018-04-20
Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation
Darbepoetin alfa - Hematologic Malignancies
Not applicableCompletedDana-Farber Cancer Institute312006-06-012009-03-13
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Stem Cell Transplant, G-CSF, Fludarabine - Hematologic Malignancies
Not applicableCompletedDartmouth-Hitchcock Medical Center182004-06-012020-11-23
G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome
Granulocyte Colony Stimulating Factor - Hematologic Malignancies
Not applicableTerminatedEmory University82004-04-012017-09-11
Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)
Granulocyte Colony Stimulating Factor - Hematologic Diseases, Hematologic Malignancies
Not applicableCompletedEmory University102003-07-012014-08-22
IUdR/BUdR Cell Cycle Labelling
Chemotherapy for hematologic malignancy - Hematologic Malignancies
Not applicableCompletedM.D. Anderson Cancer Center281992-05-012012-01-24

Narrower conditions

Hematologic Neoplasms (19)  ·  Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Multiple Myeloma (2)  ·  Thrombocytopenia (2)  ·  Anxiety Disorders (1)  ·  Fatigue (1)  ·  Febrile Neutropenia (1)  ·  Hematologic Diseases (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Myelodysplastic Syndromes (1)

Broader conditions

Hemic and Lymphatic Diseases (19)  ·  Neoplasms by Site (19)  ·  Hematologic Diseases (18)  ·  Neoplasms (18)  ·  Cytopenia (4)  ·  Neoplasms by Histologic Type (3)  ·  Agranulocytosis (2)  ·  Blood Platelet Disorders (2)  ·  Blood Protein Disorders (2)  ·  Cardiovascular Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Hemostatic Disorders (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia, Myeloid (2)

Interventions

Granulocyte Colony-Stimulating Factor (3)  ·  Blood Specimen Collection (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Darbepoetin alfa (1)  ·  Drug Therapy (1)  ·  Home Care Services (1)  ·  Methotrexate (1)  ·  Saline Solution (1)  ·  Stem Cell Transplantation (1)  ·  fludarabine (1)  ·  pegfilgrastim (1)

Sponsors

Dartmouth-Hitchcock Medical Center (2)  ·  Duke University (2)  ·  Emory University (2)  ·  Centre Hospitalier Annecy Genevois (1)  ·  Ciusss de L'Est de l'Île de Montréal (1)  ·  Dana-Farber Cancer Institute (1)  ·  Fondazione EMN Italy Onlus (1)  ·  Istanbul Aydın University (1)  ·  M.D. Anderson Cancer Center (1)  ·  Seoul National University Hospital (1)  ·  Taipei Veterans General Hospital, Taiwan (1)  ·  Terumo BCTbio (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  Universitas Airlangga (1)  ·  University of Rochester (1)

Countries

United States (12)  ·  Canada (1)  ·  France (1)  ·  Indonesia (1)  ·  Italy (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Kuang-Yueh Chiang, M.D. (2)  ·  Nelson Chao, MD, MBA (2)  ·  Daniel R Richardson, MD, MA, MSc (1)  ·  Eric Jacobsen, MD (1)  ·  Han-Wei Su (1)  ·  Hongtao Liu, MD, PhD (1)  ·  Izzatul Fithriyah, Sp.KJ (1)  ·  Jacques Galipeau, MD, FRCP(C) (1)  ·  John M Hill Jr., MD (1)  ·  John M Hill, MD (1)  ·  Kah Poh Loh (1)  ·  Kenneth R Meehan, MD (1)  ·  Michael Andreeff, MD, PhD (1)  ·  Robert Cortes, MD (1)

Results publications

PMID 10091805, PMID 17008536, PMID 17573453, PMID 18322708, PMID 18619375, PMID 20953908, PMID 22050904, PMID 22461866, PMID 22776268, PMID 23485478, PMID 23954992, PMID 24179471, PMID 25299140, PMID 25386344, PMID 25445023, PMID 25728366, PMID 26061092, PMID 26169616, PMID 26345187, PMID 26473759, PMID 28042020, PMID 28061985, PMID 28253393, PMID 28458705, PMID 28621019, PMID 28670114, PMID 28688533, PMID 28915856, PMID 29171820, PMID 29313949, PMID 29336645, PMID 29506345, PMID 29626261, PMID 30165140, PMID 30191843, PMID 30461314, PMID 30725636, PMID 31302766, PMID 31541205, PMID 31626055, PMID 32058362, PMID 32132841, PMID 32303764, PMID 32457216, PMID 32519831, PMID 32524098, PMID 32560160, PMID 32652612, PMID 33120223, PMID 33162898

NIH funding

K08CA273684 (1)